Beta Blockers and Angiotensin Receptor Blockers in Bicuspid Aortic Valve Disease Aortopathy (BAV Study).
Phase of Trial: Phase III
Latest Information Update: 14 Dec 2016
At a glance
- Drugs Atenolol (Primary) ; Telmisartan (Primary)
- Indications Aortic valve disorders
- Focus Therapeutic Use
- Acronyms BAV
- 15 Aug 2016 Status changed from recruiting to completed.
- 26 Nov 2012 Planned number of patients changed from 352 to 416 as reported by ClinicalTrials.gov.
- 14 Jul 2011 Actual initiation date (June 2011) added as reported by ClinicalTrials.gov.